Exagen Inc. (XGN) Fundamentals

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
SHARE INFORMATION
Market Cap$ 44,228,410
Shares Outstanding16,260,445
Float10,391,567
Percent Float63.91%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 48,299,000
Latest Fiscal EPS$ -1.69
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions154
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months376,485
Institutional Holdings Percent88.5%
Institutional Sold Previous 3 Months2,884,451
Insider Holdings Date2022-08-31
Insider Bought Previous 3 Months63,000
Insider Holdings Percent2.6
Insider Sold Previous 3 Months-
Insider Shares Owned425,922
TRADING INFO
52 Week High$ 14.85
52 Week Low$ 2.65
52 Week High Change$ -80.20
21 Day Moving Average$ 4.0642
21 Day Extended Moving Average$ 3.9297
50 Day Moving Average$ 5.2542
50 Day Extended Moving Average$ 4.7714
200 Day Moving Average$ 6.9497
200 Day Extended Moving Average$ 7.0812
10 Day Average Volume15,553
20 Day Average Volume12,338
30 Day Average Volume11,866
50 Day Average Volume17,479
Alpha-0.027358
Beta1.0292
Standard Deviation0.187065
R20.097619
7 Day Price Change$ -0.87
7 Day Percent Change-24.23%
21 Day Price Change$ -1.74
21 Day Percent Change-39.01%
30 Day Price Change$ -1.84
30 Day Percent Change-40.35%
Month to Date Price Change$ -1.81
Month to Date Percent Change-39.96%
Quarter to Date Price Change$ -3.02
Quarter to Date Percent Change-52.61%
180 Day Price Change$ -5.31
180 Day Percent Change-66.13%
200 Day Price Change$ -5.12
200 Day Percent Change-65.31%
Year to Date Price Change$ -8.91
Year to Date Percent Change-76.61%

Exagen Inc. (XGN) Key Ratios

PROFITABILITY
EBIT Margin-79.3%
EBITDA Margin-76.7%
Pre-Tax Profit Margin-49.2%
Profit Margin Count-86.22%
Gross Margin49.6%
Profit Margin TOT-86.22%
INCOME STATEMENTS
Revenue$ 44,296,000
Revenue Per Share$ 2.7242
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.80
Total Debt To Equity0.50
Int Coverage-13.90
Current Ratio9.30
Leverage Ratio1.50
Quick Ratio9.00
Long Term Debt To Capital0.34
VALUATION MEASURES
PE Ratio-1.30
Enterprise Value$ 4,143,059
Price to Sales0.998474
Price to Free Cash-1.30
PE High Last 5 Years0.00
Price To Book0.70
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover4.90
Invoice Turnover0.00
Assets Turnover0.50
Return Assets-33.53
Return on Equity-50.64
Return on Capital-31.70

Exagen Inc. (XGN) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorBDO USA, LLP
CEOFortunato Ron Rocca
Emplyoees222
Last AuditUQ
CIK0001274737
IndustryMedical Diagnostics & Research
SectorHealthcare
NAICSTesting Laboratories(541380)
CONTACT INFO
Address1261 Liberty Way
Suite C
Vista, CA 92081
Websitehttps://www.exagen.com
Facsimile-
Telephone+1 760 560-1501
Email-


Your Recent History
NASDAQ
XGN
Exagen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.